Advertisement

In Vitro Inhibitory Effect of Chlorpromazine on the Growth of Candida Species: A Preliminary Report

  • K. Kurtar
  • İ. Çifter
  • F. Ulutan
  • N. Sultan
  • N. Yüksel
Part of the Federation of European Microbiological Societies Symposium Series book series (FEMS, volume 50)

Abstract

Phenothiazines belong to the group of antipsychotic drugs which are frequently used in the treatment of psychotic patients. Chlorpromazine having aliphatic side chains is a prototype for phenothiazines, with significant sedative and antipsychotic effects. This drug has been widely used in the treatment of psychotic patients since 1950’s. Recently, attention was drawn to beneficiary effects on the alleviation of gastrointestinal symptoms in cholera, as the drug inhibits the enzyme adenyl cyclase, consequently decreasing the intestinal secretions, which leads to the reduction of the loss of electrolytes 1.2. It was also demonstrated that the drug had an in vitro antibacterial effect, acting as a membrane stabilizer on the strains of Staphylococcus aureus and Vibrio cholerae 3.In a previous study, we observed its outcome on a wide range of bacteria and noted the bacteriostatic results especially on Gram-positive bacteria 4. This prompted us to examine whether this drug had similar consequences on different microorganisms, and an investigation was carried out on the Candida species. According to the best of our knowledge, no such study exists in the literature.

Keywords

Salicylic Acid Antipsychotic Drug Acetyl Salicylic Acid Antibacterial Effect Candida Species 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G.H. Rabbani, J. Holmgren, W.B. Greenough III and I. Lönnroth, Chlorpromazine reduces fluid loss in cholera, Lancet, 1: 410 (1979).PubMedCrossRefGoogle Scholar
  2. 2.
    G.H. Rabbani, W.B. Greenough III, J. Holmgren and B. Kirkwood, Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously, Br. Med. J., 284: 1361 (1982).CrossRefGoogle Scholar
  3. 3.
    J.E.H. Kristiansen and K. Gaarslev, The antibacterial effects of selected neroleptics on Vibrio cholerae, Acta Pathol. Microbiol. Immunol. Scand. B, 93: 49 (1985).Google Scholar
  4. 4.
    İ. Çi£ter, K. Kurtar, N. Sultan, N. Yüksel and F. Ulutan, A preliminary study: In vitro antibacterial activity of chlorpromazine. Gazi Üniv. Tip Fak. Derq., 4: 505 (1988).Google Scholar
  5. 5.
    A.W. Bauer, W.M.M. Kirby, J.C. Sherris and M. Turck, Antibiotic susceptibility testing by a standardised single disc method, Am. J. Clin. Pathol., 45: 493 (1966).PubMedGoogle Scholar
  6. 6.
    A.E. Swingyard, Psychopharmacologic agents, in: “Remington’s Pharmaceutical Sciences”, 16th edition, pp. 1029–1042, A. Osol, ed., Mack Publishing Company, (1980).Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • K. Kurtar
    • 1
  • İ. Çifter
    • 2
  • F. Ulutan
    • 1
  • N. Sultan
    • 3
  • N. Yüksel
    • 2
  1. 1.Department of Infectious Diseases, Faculty of MedicineGazi UniversityAnkaraTurkey
  2. 2.Department of Psychiatry, Faculty of MedicineGazi UniversityAnkaraTurkey
  3. 3.Department of Microbiology, Faculty of MedicineGazi UniversityAnkaraTurkey

Personalised recommendations